[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Asset Management Plc LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 39.00 38.00 40.00 39.00 39.00 39.00 2,012 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 23.4 34.0 7.8 5.0 172

Mercia Asset Management Share Discussion Threads

Showing 926 to 949 of 1250 messages
Chat Pages: Latest  38  37  36  35  34  33  32  31  30  29  28  27  Older
DateSubjectAuthorDiscuss
12/8/2020
14:06
3% share register needs addressing. It looks relatively weak but that can change with results. Too much in hands < 3%.
p1nkfish
12/8/2020
13:57
As soon as one of my other punts pay off, I'll add here - this feels like a good long term play, pinks notes taken into account D
dennisbergkamp
12/8/2020
13:34
New games payment platform will accept real money (12th August 2020). A company which has developed a new payment system for the games industry has secured a further £200k investment from the MEIF Proof of Concept & Early Stage Fund, managed by Mercia and part of the Midlands Engine Investment Fund (MEIF). Transaction Technologies’ new platform will target the multi-billion-dollar market for in-game downloads. PlayerLands, as it is known, allows players to buy virtual goods within games and is one of the few systems that will accept payments in real money rather than cryptocurrencies. The platform provides a secure payment system that makes it easy to buy and sell virtual products online and for developers to set up their own stores, market their goods and manage their businesses. The latest funding round will allow the Derby-based firm to finalise and launch its platform, while creating four new jobs in Derby for developers and customer service staff. Transaction Technologies was set up by serial entrepreneurs Alex Booth and Nick Gillett (pictured). Booth has worked as a consultant in the gaming industry while Gillett is a games industry journalist and former Guardian columnist who has successfully exited previous start-ups. Having secured an initial £200k investment from MEIF to build the platform, the entrepreneurshave now successfully integrated it with the leading payment systems and are in discussions with a number of games developers. Nick Gillett said: “The games business, and especially the highly social world of server-based games, have been growing rapidly for years. We make it easy for developers and server owners to monetise their services, leaving them to concentrate on making the best entertainment.”; Sandy Reid, Investment Director at Mercia, added: “Online gaming is an exciting sector that has grown significantly during the global lockdown. Transaction Technologies is filling a gap in the market for a secure and professional payment system. We are pleased to further support the business with this latest investment which will allow it to launch PlayerLands and to capitalise on the favourable market conditions.” Lewis Stringer, Senior Manager at the British Business Bank, said: “The MEIF Proof of Concept & Early Stage Fund was set up to support start-ups across the region looking to get a business idea off the ground initially and then, grow with further investment. Transaction Technologies is a good example of this, with the MEIF initially providing funding to help the firm develop its platform and now supporting a second round of funding enabling it to launch to market.” Sajeeda Rose, CEO at D2N2 LEP, said: “Our area has a thriving creative & digital industry and I’m pleased to see continued investment by the Midlands Engine Investment Fund into innovative businesses such as Transaction Technologies which can help drive our economic recovery by creating high-skilled jobs in our region.” Tom Gray, Partner at Knights plc, provided legal advice to the fund. The Midlands Engine Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.
sev22
12/8/2020
09:59
I'm think a much, much better growth punt by a big margin to a boring FTSE250 tracker and not so bleeding edge as to need a PHD to understand the holdings and business model.
p1nkfish
12/8/2020
09:57
Depends on your time frames. Look at 2yr weekly & 5yr weekly. 1 yr daily is a different kettle of fish. If momentum builds here it has probably turned but a consistent uptrend is not yet in place imho. I think it is turning but TA depends on the time frames. Already held but recently looked over portfolio again and did some digging and some are maturing and others coming along nicely so added a fair amount. There is an old "Shares" video on YouTube that I re-watched too as a reminder. Sci Warehouse exit was rubbish but I think better to come and diverse.
p1nkfish
12/8/2020
09:09
From a technical analysis point of view the stock is now a 'strong buy' having just moved through the 100 day moving average of 20.3p.
sev22
12/8/2020
09:08
I have the management on a 'very' short fuse! That aside, and given the wide array of vaccines in development, with over 200 candidate vaccines in development, and 15 in clinical trials already (see article below). One of Mercia's portfolio companies, OXGENE, might be receiving increased enquiries. OXGENE's expertise in DNA design and engineering, cell line development, upstream and downstream processing, and industry-leading automation, is thus likely to have received at least some interest from vaccine developers. OXGENE Ryan founded Oxford Genetics in 2011 with the aim to revolutionise DNA design, optimisation and assembly to enable molecular engineering to fulfil its promise in synthetic biology and medicine. Ryan has a first class degree in Genetics and a Ph.D. from Oxford University. He is an experienced genetic engineer with extensive knowledge and practical insight working with bacterial, botanical and mammalian recombinant expression systems. Ryan's research interests in synthetic biology and molecular engineering include vaccines and treatments for infectious diseases and cancer. He was inspired to create Oxford Genetics after observing that inefficient DNA design and assembly often limit scientific progress. hTTps://www.oxgene.com/Our-People/Board-of-Directors/Dr-Ryan-Cawood-1 Our discoveries and processes enable pharmaceutical and biotechnology companies unparalleled performance in developing new commercially viable drug therapies and vaccines. hTTps://www.oxgene.com/About-Oxgene/Oxford-Genetics-our-history Even an announcement of involvement in coronavirus vaccines would be positive for the share price (given reactions elsewhere!). The following vaccine article provides for an excellent read - This coronavirus vaccine would be two breakthroughs in one By STEPHEN BURANYI Tuesday 11 August 2020 hTTps://www.wired.co.uk/article/coronavirus-vaccine-mrna
wan
12/8/2020
08:24
The downtrend since Jan 2015 has been unrelenting. That is a drag on sentiment and has not been helped by management attitude to PIs.
p1nkfish
11/8/2020
17:45
20.5p - need to break through with a bit of oomph and then trend is set to change imho. Today was interesting.
p1nkfish
11/8/2020
16:47
Looked over holding periods and in next 2 years should be some exits imho or at least a few reaching some maturity.
p1nkfish
11/8/2020
16:47
Looked over holding periods and in next 2 years should be some exits imho or at least a few reaching some maturity.
p1nkfish
11/8/2020
16:00
I wonder if Simon Thompson will change his mind on Mercia, a IC recommendation would move the price. Although i think proving the portfolio value via profitable exits is what will ultimately drive the price here.
waterfall city
11/8/2020
15:11
https://www.investegate.co.uk/mercia-asset-mgt-plc--merc-/rns/director-pdmr-dealings/202007291431095120U/ Just a reminder that we saw four Directors adding to their personal stakes in Mercia less than two weeks ago.
sev22
11/8/2020
15:11
It's turning. Have been buying for that reason. Still have a beef with a few things but downside looks reasonable vs potential upside. Spotlight on management. If they screw up at this point there is no hope for any of them/us.
p1nkfish
11/8/2020
14:33
"I have inexplicable feeling this is going to move up soon. Soon could be weeks or a couple of months." Nothing changed there then! This share is always 'jam tomorrow'.
nocton
11/8/2020
14:27
I have a reasonable stake here, but waiting to see if management can actually deliver a tangible and positive effect for 'all' shareholders via material exit/s, which should result in a significant 'jump' start to a re-rating, which might have legs.
wan
11/8/2020
13:53
Now positioned to take advantage if it does. dyor etc.
p1nkfish
11/8/2020
13:52
I have inexplicable feeling this is going to move up soon. Soon could be weeks or a couple of months.
p1nkfish
10/8/2020
15:04
10th August, 2020 👏👏&#128079; Congratulations to our portfolio company @OXGENEofficial, who have made the list of the UK’s 10 fastest-growing companies compiled by @Beauhurst CEO Dr. Ryan Cawood explains how Mercia’s investment has transformed their company from very humble beginnings. #biotech
sev22
10/8/2020
09:43
10th August, 2020. 🎮 @nDreamsVR 📍 Farnborough 🏆 Award-winning VR developers 👏 Phantom: Covert Ops ranked #1 @patrickol & @juliep_1 explain the rise of VR gaming, being a market leader and scaling their team for big future plans. #vr #regions #investment #gaming
sev22
04/8/2020
19:10
Legaltech business raises £6m for international growth (4th August 2020). Fast-growing legaltech business Clarilis has raised a further £6m in a Series B investment to support its ongoing growth. The funding has come from Mercia’s Northern Venture Capital Trust Funds (VCTs), which were an existing investor in the business, and Gresham House Ventures, investing on behalf of the Baronsmead VCTs. The funding will assist the company’s continued international growth and fund its sales, marketing and product development activities. Clarilis, which is based in Leamington Spa and has an office in Singapore, is a leading provider of automated drafting technology. Its CLARILIS™ platform was designed to automate complex suites of precedents, such as Share Purchase and Facility Agreement suites with many ancillaries, parties and complex underlying deal structures. CLARILIS™ saves significant amounts of lawyer time whilst ensuring that law firms and in-house legal departments draft consistently high-quality documentation. This creates time for solicitors to focus on what they do best – providing bespoke advice to clients and handling non-standard aspects of transactions. Clarilis was co-founded by brothers James Quinn, a former solicitor, and Kevin Quinn, the technical architect of the CLARILIS™ platform and former lead developer. Since its launch in 2015, it has experienced consistently strong growth and now boasts an impressive blue-chip client base including Addleshaw Goddard, Baker McKenzie, GoCompare, National Grid and Slaughter and May. Henry Alty, Investment Director at Gresham House Ventures, said: “While the legal world has arguably been a late adopter of technology, firms are realising that automation is essential to driving both cost efficiency and resilience across distributed workforces. “In Clarilis we have found an ambitious business with a market-leading solution and exceptional customer satisfaction as a result of its fully managed service. It exemplifies the type of technology-driven and scalable business model that our investment team look for. We’ve been impressed by the impact that Clarilis has already had in the market and as the business expands, particularly into the South East Asian market, we are excited to be bringing our experience to bear and to help facilitate its growth.” Tim Levett, Investment Chairman of Mercia Northern VCTs, commented: “We are pleased to be investing once again in this leading LegalTech business, particularly in this current environment where the rapid adoption of user-friendly consumer software has fundamentally changed user expectations within enterprise. Regardless of the complexities of any business process, elegant automation and consumer-grade UX are the critical success factors that have set Clarilis and its platform apart, especially filling the void left by legacy software in this sector. “Mercia’s strong tech and SaaS investment credentials and experience combined with our ability to invest through the lifecycle of a business will be important to support the team at Clarilis as they continue to scale the business.” James Quinn, CEO and co-founder of Clarilis, added: “It’s fantastic to have the continued support from the investment team at Mercia Asset Management and I’m really pleased they’re backing us again. We are also delighted that Gresham House has chosen to invest. Gresham House were the clear choice here given Henry Alty and James Hendry’s in-depth knowledge of the LegalTech space and excellent insight. The Gresham House team also share our vision for the development of the Clarilis platform going forward. “This investment will provide the resources required to bring significant enhancements to our platform and to further scale the Clarilis team both in the UK and abroad. The uniqueness of Clarilis’ intelligent drafting platform and managed service is resonating with organisations globally – particularly as current market conditions highlight the importance of technology that can provide a strategic advantage.”
sev22
02/8/2020
12:02
Thank you for the link. Edison have produced an excellent detailed research report on Mercia here which all investors would be well advised to read. Mercia’s shares continue to trade at a severe discount to current NAV of 32.1p per share. Add the additional 4.5p per share set out below gives a potential total value of at least 36.6p versus a latest closing price of 18.5p (shares are trading at half price). Valuation: 0.60x NAV + £20m for MFM Mercia’s shares continue to trade at a discount to NAV (0.60x), even before considering the embedded value of Mercia Fund Managers (MFM), which we estimate could be worth an additional 4.5p per share or more on top of NAV. Catalysts for a re-rating include further scaling of the business, commercialisation of the direct investment portfolio and/or successful exits.
sev22
01/8/2020
17:24
hxxps://www.edisongroup.com/publication/scaling-sustainable-and-evergreen-by-fy22/27310/ Latest note on Mercia from Edison.
weatherman
31/7/2020
08:14
https://www.mercia.co.uk/webinar-the-native-antigen-company-exit-for-mercia-eis-fund/
sev22
Chat Pages: Latest  38  37  36  35  34  33  32  31  30  29  28  27  Older
ADVFN Advertorial
Your Recent History
LSE
MERC
Mercia Ass..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211024 17:53:26